543904 logo

Mankind Pharma BSE:543904 Stock Report

Last Price

₹2.37k

Market Cap

₹947.2b

7D

-1.4%

1Y

n/a

Updated

01 May, 2024

Data

Company Financials +

Mankind Pharma Limited

BSE:543904 Stock Report

Market Cap: ₹947.2b

543904 Stock Overview

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally.

543904 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance6/6
Financial Health5/6
Dividends0/6

Mankind Pharma Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Mankind Pharma
Historical stock prices
Current Share Price₹2,366.00
52 Week High₹2,488.65
52 Week Low₹1,240.75
Beta0
1 Month Change2.32%
3 Month Change15.73%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO66.15%

Recent News & Updates

Recent updates

Shareholder Returns

543904IN PharmaceuticalsIN Market
7D-1.4%1.4%1.2%
1Yn/a57.1%45.3%

Return vs Industry: Insufficient data to determine how 543904 performed against the Indian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 543904 performed against the Indian Market.

Price Volatility

Is 543904's price volatile compared to industry and market?
543904 volatility
543904 Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.7%
10% most volatile stocks in IN Market10.0%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 543904 has not had significant price volatility in the past 3 months.

Volatility Over Time: 543904's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198618,468Sheetal Arorawww.mankindpharma.com

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations.

Mankind Pharma Limited Fundamentals Summary

How do Mankind Pharma's earnings and revenue compare to its market cap?
543904 fundamental statistics
Market cap₹947.15b
Earnings (TTM)₹17.27b
Revenue (TTM)₹99.46b

54.8x

P/E Ratio

9.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
543904 income statement (TTM)
Revenue₹99.46b
Cost of Revenue₹32.36b
Gross Profit₹67.11b
Other Expenses₹49.84b
Earnings₹17.27b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)43.11
Gross Margin67.47%
Net Profit Margin17.36%
Debt/Equity Ratio2.1%

How did 543904 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.